Evidence map›Paper›PMID 29507191›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

dCas9-targeted locus-specific protein isolation method identifies histone gene regulators.

Chiahao Tsui, Carla Inouye, Michaella Levy, Andrew Lu, Laurence Florens, Michael P Washburn, Robert Tjian

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 77 citations in OpenAlex.

  1. Phosphoproteomic dysregulation promotes tumor proliferation in Cushing's disease.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Mitochondrial NADP(H)-dependent de novo dTMP biosynthesis counteracts the cytotoxicity of PARP inhibitors.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Expanding the CRISPR/Cas toolkit: applications in proteomics and theranostics.Frontiers in bioengineering and biotechnology · 2025
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. CRISPR/Cas9 Landscape: Current State and Future Perspectives.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chiahao TsuiDepartment of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.
Carla InouyeDepartment of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.
Michaella LevyStowers Institute for Medical Research, Kansas City, MO 64110.
Andrew LuDepartment of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720.
Laurence FlorensStowers Institute for Medical Research, Kansas City, MO 64110.ORCID 0000-0002-9310-6650
Michael P WashburnStowers Institute for Medical Research, Kansas City, MO 64110.
Robert TjianDepartment of Molecular and Cell Biology, Li Ka Shing Center for Biomedical and Health Sciences, California Institute for Regenerative Medicine Center of Excellence, University of California, Berkeley, CA 94720; jmlim@berkeley.edu.
Howard Hughes Medical Institute · USStowers Institute for Medical Research · USCalifornia Institute for Regenerative Medicine · US

Funding

Tools For Imaging the Functional Genome in Living Cells and TissuesU01DA047729 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI DARZACQ, XAVIER, SINGER, ROBERT H · 2018 to 2019
$1.7M
Howard Hughes Medical InstituteNIDA NIH HHS U01 DA047729
6 · The paper itself

Abstract

Eukaryotic gene regulation is a complex process, often coordinated by the action of tens to hundreds of proteins. Although previous biochemical studies have identified many components of the basal machinery and various ancillary factors involved in gene regulation, numerous gene-specific regulators remain undiscovered. To comprehensively survey the proteome directing gene expression at a specific genomic locus of interest, we developed an in vitro nuclease-deficient Cas9 (dCas9)-targeted chromatin-based purification strategy, called "CLASP" (Cas9 locus-associated proteome), to identify and functionally test associated gene-regulatory factors. Our CLASP method, coupled to mass spectrometry and functional screens, can be efficiently adapted for isolating associated regulatory factors in an unbiased manner targeting multiple genomic loci across different cell types. Here, we applied our method to isolate the

Indexed as

3' Untranslated RegionsAnimalsBacterial ProteinsChromatinChromatin ImmunoprecipitationChromosomal Proteins, Non-HistoneCRISPR-Associated Protein 9Drosophila melanogasterDrosophila ProteinsEndonucleasesGene ExpressionGenes, RegulatorHistonesHumansPromoter Regions, GeneticRecombinant Proteins3' Untranslated RegionsBacterial ProteinsCas9 endonuclease Streptococcus pyogenesChromatinChromosomal Proteins, Non-HistoneCRISPR-Associated Protein 9Drosophila ProteinsEndonucleasesHistonesRecombinant ProteinsRNA-Binding ProteinsRNA, Guide, CRISPR-Cas SystemsVig2 protein, DrosophilaVIG protein, DrosophilaCRISPR/Cas9gene expressionhistone regulationreverse ChIP

Identifiers

PMID29507191
PMCPMC5866577
OpenAlexW2793568153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.